Dacron vs Dardik for Fem-Pop Bypass

Radboud University Medical Center

Overview

Clinical trial for the comparison of long-term patency of heparin-bonded Dacron and human umbilical vein vascular prostheses in above-knee femoro-popliteal bypass surgery.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Conditions

Intermittent Claudication Arterial Occlusive Diseases Atheroslerosis

Interventions

heparin-bonded and collagen coated polysterDEVICE

femoro-popliteal bypass

Human umbilical vein femoro-popliteal bypassDEVICE

Eligibility

Sex: ALLMin age: 31 YearsMax age: 89 Years

Medical Language ↔ Plain English

Inclusion Criteria: * age 31 to 89 * intermittent claudication * ABI below 0.8 Exclusion Criteria: * non elective surgery * life expectancy below 2 yrs * contraindication for anticoagulant therapy

Locations (1)

Radboud UMCN, Dept Vascular Surgery

Nijmegen, Netherlands

Outcomes

Primary Outcomes

Primary and primary-assisted bypass patency

Time frame: 1 - 5 yrs

Secondary Outcomes

Secondary bypass patency

Time frame: 1 - 5 yrs

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.